Surgical Blood Loss Clinical Trial
Official title:
A Prospective Study of Enucleation of Pancreatic Tumor by Blocking Abdominal Trunk and Superior Mesenteric Artery
Pancreatic enucleation could preserve more healthy pancreatic tissues and functions with a low recurrence risk. However, conventional enucleation can cause significant intraoperative bleeding, especially in which tumors in the pancreatic head, neck, and uncinate process of pancreas, as these tissues are rich in blood supply, mainly including the abdominal trunk and the superior mesenteric artery. In this study, we developed a novel method to control the pancreatic blood flow in laparoscopic enucleation--blocking the abdominal trunk and superior mesenteric artery with vascular occlusion clips in the process of resection, and evaluated its effectiveness and safety.
Between March 2023 and May 2026, patients who underwent laparoscopic pancreatic enucleation by blocking both the abdominal trunk and superior mesenteric artery in the Second Affiliated Hospital of Zhejiang University would be included in our prospective study. Inclusion criteria: 1) benign or borderline tumors diagnosed pathologically, such as pancreatic neuroendocrine tumors, solid pseudopapillary tumors, and cystadenomas, without vascular invasion or distant metastasis;.2) tumors sited in the pancreatic head, neck, and uncinate process of pancreas; 3) blockade of both the abdominal trunk and superior mesenteric artery in the laparoscopic enucleation. Exclusion criteria:1) highly malignant pancreatic tumors, or tumors with infiltration or metastasis; 2) tumors of the body and tail of the pancreas;3) transfer to LPD or laparotomy. Patient characteristic including clinical, biochemical and radiological data will be recorded and analyzed. All patients will provide written informed consent before inclusion. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04588350 -
Clinical Investigation Evaluating a New Autotransfusion Device in Cardiac Surgery
|
N/A | |
Completed |
NCT00985920 -
Topical Tranexamic Acid for Total Knee Arthroplasty
|
Phase 4 | |
Terminated |
NCT03954314 -
DEPOSITION - Decreasing Postoperative Blood Loss by Topical vs. Intravenous Tranexamic Acid in Open Cardiac Surgery
|
Phase 3 | |
Completed |
NCT04040023 -
Patient Blood Management in Cardiac Surgery
|
N/A | |
Withdrawn |
NCT05672407 -
The Role of Local Tranexamic Acid on Periorbital Oculoplastic Surgery
|
Phase 4 | |
Not yet recruiting |
NCT05379530 -
TEG Use in Children Undergoing Procedures With High Anticipated Blood Loss
|
N/A | |
Recruiting |
NCT03740438 -
Modeling of the Hemoglobin Drop in the Uncomplicated Postoperative Course
|
||
Completed |
NCT05708690 -
Topical Effect of Tranexamic Acid in Postoperative Bleeding and Blood Products Transfusion After Cardiac Surgery
|
Phase 4 | |
Completed |
NCT04143373 -
Effect of Warm Saline Irrigation on Bleeding in Mandibular Third Molar Surgery
|
N/A | |
Completed |
NCT02996006 -
New Techniques to Reduce Intra-operative Bleeding During Complex Liver Resection
|
N/A | |
Completed |
NCT03313583 -
French One Day Survey in 2011 - Knowing Our Population of Labile Blood Products Recipients
|
N/A | |
Completed |
NCT03952546 -
To Evaluate the Safety and Efficacy of the Saline-coupled Bipolar Sealer in Primary Unilateral Total Knee Arthroplasty
|
N/A | |
Active, not recruiting |
NCT03426839 -
Haemostasis Management of Abdominal Aortic Procedures
|
N/A | |
Completed |
NCT05780125 -
Effectiveness of Different Fibrinogen Preparations in Restoring Clot Firmness
|
Phase 2 | |
Completed |
NCT04025736 -
Arthroscopic Shoulder Surgery With Administration of Intravenous Tranexamic Acid
|
N/A | |
Recruiting |
NCT02580227 -
Tranexamic Acid in Intertrochanteric and Subtrochanteric Femur Fractures
|
Phase 4 | |
Terminated |
NCT03160170 -
Efficacy of Suction Enabled Retraction Device
|
N/A | |
Not yet recruiting |
NCT06414031 -
Tranexamic Acid for Reduction of Transfusion in Abdominal Surgery
|
Phase 3 | |
Withdrawn |
NCT03340116 -
Measurement of Blood Volume Loss During Burn Surgery
|
||
Completed |
NCT01475669 -
Study of Fibrinogen Concentrate (Human) (FCH) to Control Bleeding During Complex Cardiovascular Surgery
|
Phase 3 |